to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Venture firms are approaching angel investor groups to co-invest at the growth stage of startups. Read more about the impact this could have on startup health IT companies.
Medical foundations play a role in helping medicine advance through their philanthropy, but sometimes even the most well-intentioned of them can lose their way. Read more about how these foundations can stay focused on their goals.
Many would agree that surgeons are qualified to create innovative medical devices that may be superior to what is currently available. But the controversy arises when surgeons begin to profit by purchasing their own products for use in their patients.
In a venture funding climate seeking large returns, thousands of potentially successful entrepreneurial startups can't get the financing they need to make a difference in the economy and in the culture. The problem isn't a new one, but it is a damaging one.
The number of healthcare venture deals is at its lowest level in at least five quarters, according to a new report. However, healthcare seed investment hit a record high in the same quarter.
There's stability and then there's outright growth. For healthcare business owners looking for angel funding, they'll have to accept the former and wait some more on the latter. But at least it's progress.
Regenerative medicine has come a long way in recent years, leading some venture capitalists to consider investing in it. The roadblock to investing in this field is not a lack of funds, but rather a lack of a clear explanation of regenerative medicine's commercial applications, says one former venture capitalist.
Landing an angel investment takes a special approach. Learn from the advice of those who've tried and succeeded at lining up angel investors for their healthcare businesses.
Pharmaceutical companies are trying to adapt their marketing to an increasingly digital world. To get a handle on this environment, one company has appointed a digital advisory board of marketers from other industries.
Pharma reps at GSK are selling their products in a new way. The emphasis is more on communicating a drug's benefits and risks than trying to sell as much as possible. Read more about this change in approach to sales.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.